+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bovine Mastitis Drugs & Diagnostics Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth

  • ID: 5232521
  • Report
  • December 2020
  • Region: Global
  • 378 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Elanco Animal Health
  • Merck and Co., Inc.
  • Zoetis Inc.
  • MORE
Bovine Mastitis Drugs & Diagnostics Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global Bovine Mastitis Drugs & Diagnostics market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.
Description:

Where is the largest and fastest growing market for Bovine Mastitis Drugs & Diagnostics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Bovine Mastitis Drugs & Diagnostics market opportunities and strategies to 2030 report answers all these questions and many more.

The report covers the following chapters
  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Market Characteristics - The market characteristics section of the report defines and explains the bovine mastitis drugs and diagnostics market. This chapter also defines and describes goods and related services covered in the report.
  • Trends and Strategies - This chapter describes the major trends shaping the global bovine mastitis drugs and diagnostics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the bovine mastitis drugs and diagnostics market.
  • Global Market Size and Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global bovine mastitis drugs and diagnostics market, estimated market shares and company profiles for the leading players.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for bovine mastitis drugs and diagnostics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report
Markets Covered: The global bovine mastitis drugs & diagnostics market is segmented by -
  • By Product: Antibiotics; Pain Relievers; Surgery; Vaccines; Others
  • By Disease: Clinical Mastitis; Sub-clinical Mastitis
  • By Type: CMT Kits; PCR Testing; On-Farm Diagnostic Kits; Others
  • By End Use: Hospitals and Clinics; Veterinary Centers
Companies Mentioned: Zoetis Inc.; Elanco Animal Health; Boehringer Ingelheim International GmbH; Bayer AG; Merck and Co., Inc.

Countries: Japan, India, Australia, New Zealand, Brazil, Spain, USA, UK, Germany, France, Italy,

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer AG
  • Elanco Animal Health
  • Merck and Co., Inc.
  • Zoetis Inc.
  • MORE
1. Bovine Mastitis Drugs & Diagnostics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Bovine Mastitis Drugs & Diagnostics Market Characteristics
6.1. Market Definition
6.2. Bovine Mastitis Drugs Market Segmentation by Product
6.2.1. Antibiotics
6.2.2. Pain Relievers
6.2.3. Surgery
6.2.4. Vaccines
6.2.5. Others
6.3. Bovine Mastitis Drugs Market Segmentation by Disease
6.3.1. Clinical Mastitis
6.3.2. Sub-clinical Mastitis
6.4. Bovine Mastitis Diagnostics Market Segmentation by Type
6.4.1. CMT Kits
6.4.2. PCR Testing
6.4.3. On-Farm Diagnostic Kits
6.4.4. Others
6.5. Bovine Mastitis Drugs and Diagnostics Market Segmentation by End Use
6.5.1. Hospitals and Clinics
6.5.2. Veterinary Centers
6.5.3. Others

7. Bovine Mastitis Drugs & Diagnostics Market Trends and Strategies
7.1. Application of Nanotechnology in Bovine Mastitis Drugs To Tackle Antibiotic Resistance
7.2. Research and Development Activities To Develop Mastitis Diagnostic Kits
7.3. Use of Biosensors For Bovine Mastitis Diagnosis
7.4. Development of Non-Antibiotic Treatment For Bovine Mastitis
7.5. Machine Learning To Improve Diagnosis of Bovine Mastitis

8. COVID-19 Impact: Bovine Mastitis Drugs and Diagnostics Market
8.1. Supply Side Factors
8.1.1. Impact On Leading Global Animal Medicine Companies
8.1.2. Decline in The Launch of New Products
8.2. Safety Measures Being Followed by Bovine Mastitis Drugs Manufacturers
8.2.1. Demand Side Factors
8.2.2. Stockpiling of Bovine Mastitis Drugs (Panic Purchasing)
8.2.3. Only Emergency Services Being Offered by Veterinarians

9. Global Bovine Mastitis Drugs & Diagnostics Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, 2015-2019, Value ($ Million)
9.2.1. Drivers of The Market 2015-2019
9.2.2. Restraints On The Market 2015-2019
9.3. Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
9.3.1. Drivers of The Market 2019-2023
9.3.2. Restraints On The Market 2019-2023

10. Global Bovine Mastitis Drugs & Diagnostics Market Segmentation
10.1. Global Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
10.1.1. Bovine Mastitis Drugs
10.1.2. Bovine Mastitis Diagnostics
10.2. Global Bovine Mastitis Drugs & Diagnostics Market, Segmentation by End Use, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
10.2.1. Veterinary Centers
10.2.2. Hospitals & Clinics
10.2.3. Other End Use
10.2.4. Global Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
10.2.5. CMT Kits
10.2.6. On-Farm Diagnostic Kits
10.2.7. PCR Testing
10.2.8. Others
10.2.9. Global Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
10.2.10. Antibiotics
10.2.11. Pain Relievers
10.2.12. Vaccines
10.2.13. Surgery
10.2.14. Other Product
10.2.15. Global Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
10.2.16. Sub-Clinical Mastitis
10.2.17. Clinical Mastitis

11. Bovine Mastitis Drugs & Diagnostics Market, Regional and Country Analysis
11.1. Global Bovine Mastitis Drugs & Diagnostics Market, by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
11.2. Global Bovine Mastitis Drugs & Diagnostics Market, by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

12. Asia-Pacific Bovine Mastitis Drugs & Diagnostics Market
12.1. Asia Pacific Bovine Mastitis Drugs & Diagnostics Market Overview
12.1.1. Region Information
12.1.2. Market Information
12.1.3. COVID-19 Impact
12.1.4. Background Information
12.1.5. Government Initiatives
12.1.6. Regulatory Bodies
12.1.7. Regulations
12.1.8. Corporate Tax Structure
12.1.9. Associations
12.1.10. Tax Levied
12.1.11. Investments
12.1.12. Major Companies
12.2. Asia-Pacific Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
12.3. Asia-Pacific Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
12.4. Asia-Pacific Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.5. Asia-Pacific Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.6. Asia-Pacific Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.7. Asia-Pacific Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.8. Asia-Pacific Bovine Mastitis Drugs & Diagnostics Market: Country Analysis
12.9. India Bovine Mastitis Drugs & Diagnostics Market
12.10. India Bovine Mastitis Drugs & Diagnostics Market Overview
12.10.1. Country Information
12.10.2. Market Information
12.10.3. COVID-19 Impact
12.10.4. Background Information
12.10.5. Government Initiatives
12.10.6. Regulatory Bodies
12.10.7. Regulations
12.10.8. Corporate Tax Structure
12.10.9. Associations
12.10.10. Tax Levied
12.10.11. Investments
12.10.12. Major Companies
12.11. India Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
12.12. India Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
12.13. India Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.14. India Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.15. India Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.16. India Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.17. Japan Bovine Mastitis Drugs & Diagnostics Market
12.18. Japan Bovine Mastitis Drugs & Diagnostics Market Overview
12.18.1. Country Information
12.18.2. Market Information
12.18.3. COVID-19 Impact
12.18.4. Background Information
12.18.5. Government Initiatives
12.18.6. Regulatory Bodies
12.18.7. Regulations
12.18.8. Corporate Tax Structure
12.18.9. Associations
12.18.10. Tax Levied
12.18.11. Major Companies
12.19. Japan Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
12.20. Japan Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
12.21. Japan Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.22. Japan Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.23. Japan Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.24. Japan Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.25. Australia Bovine Mastitis Drugs & Diagnostics Market
12.26. Australia Bovine Mastitis Drugs & Diagnostics Market Overview
12.26.1. Country Information
12.26.2. Market Information
12.26.3. COVID-19 Impact
12.26.4. Background Information
12.26.5. Regulatory Bodies
12.26.6. Regulations
12.26.7. Corporate Tax Structure
12.26.8. Associations
12.26.9. Tax Levied
12.26.10. Major Companies
12.27. Australia Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
12.28. Australia Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
12.29. Australia Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.30. Australia Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.31. Australia Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.32. Australia Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.33. New Zealand Bovine Mastitis Drugs & Diagnostics Market
12.34. New Zealand Bovine Mastitis Drugs & Diagnostics Market Overview
12.34.1. Country Information
12.34.2. Market Information
12.34.3. COVID-19 Impact
12.34.4. Background Information
12.34.5. Government Initiatives
12.34.6. Regulatory Bodies
12.34.7. Regulations
12.34.8. Corporate Tax Structure
12.34.9. Associations
12.34.10. Tax Levied
12.34.11. Investments
12.34.12. Major Companies
12.35. New Zealand Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
12.36. New Zealand Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
12.37. New Zealand Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.38. New Zealand Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.39. New Zealand Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
12.40. New Zealand Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

13. Western Europe Bovine Mastitis Drugs & Diagnostics Market
13.1. Western Europe Bovine Mastitis Drugs & Diagnostics Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. COVID-19 Impact
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulatory Bodies
13.1.7. Regulations
13.1.8. Corporate Tax Structure
13.1.9. Tax Levied
13.1.10. Associations
13.1.11. Investments
13.1.12. Major Companies
13.2. Western Europe Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
13.3. Western Europe Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.4. Western Europe Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.5. Western Europe Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.6. Western Europe Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.7. Western Europe Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.8. Western Europe Bovine Mastitis Drugs & Diagnostics Market: Country Analysis
13.9. UK Bovine Mastitis Drugs & Diagnostics Market
13.10. UK Bovine Mastitis Drugs & Diagnostics Market Overview
13.10.1. Country Information
13.10.2. Market Information
13.10.3. COVID-19 Impact
13.10.4. Background Information
13.10.5. Government Initiatives
13.10.6. Regulatory Bodies
13.10.7. Regulations
13.10.8. Corporate Tax Structure
13.10.9. Associations
13.10.10. Investments
13.10.11. Major Companies
13.11. UK Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
13.12. UK Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.13. UK Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.14. UK Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.15. UK Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.16. UK Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.17. Germany Bovine Mastitis Drugs & Diagnostics Market
13.18. Germany Bovine Mastitis Drugs & Diagnostics Market Overview
13.18.1. Country Information
13.18.2. Market Information
13.18.3. COVID-19 Impact
13.18.4. Background Information
13.18.5. Regulatory Bodies
13.18.6. Regulations
13.18.7. Corporate Tax Structure
13.18.8. Tax Levied
13.18.9. Associations
13.18.10. Major Companies
13.19. Germany Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
13.20. Germany Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.21. Germany Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.22. Germany Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.23. Germany Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.24. Germany Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.25. France Bovine Mastitis Drugs & Diagnostics Market
13.26. France Bovine Mastitis Drugs & Diagnostics Market Overview
13.26.1. Country Information
13.26.2. Market Information
13.26.3. COVID-19 Impact
13.26.4. Background Information
13.26.5. Regulatory Bodies
13.26.6. Regulations
13.26.7. Corporate Tax Structure
13.26.8. Tax Levied
13.26.9. Associations
13.26.10. Major Companies
13.27. France Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
13.28. France Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.29. France Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.30. France Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.31. France Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.32. France Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.33. Italy Bovine Mastitis Drugs & Diagnostics Market
13.34. Italy Bovine Mastitis Drugs & Diagnostics Market Overview
13.34.1. Country Information
13.34.2. Market Information
13.34.3. COVID-19 Impact
13.34.4. Background Information
13.34.5. Government Initiatives
13.34.6. Regulatory Bodies
13.34.7. Regulations
13.34.8. Corporate Tax Structure
13.34.9. Tax Levied
13.34.10. Associations
13.34.11. Major Companies
13.35. Italy Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
13.36. Italy Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.37. Italy Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.38. Italy Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.39. Italy Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.40. Italy Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.41. Spain Bovine Mastitis Drugs & Diagnostics Market
13.42. Spain Bovine Mastitis Drugs & Diagnostics Market Overview
13.42.1. Country Information
13.42.2. Market Information
13.42.3. COVID-19 Impact
13.42.4. Background Information
13.42.5. Regulatory Bodies
13.42.6. Regulations
13.42.7. Corporate Tax Structure
13.42.8. Tax Levied
13.42.9. Associations
13.42.10. Investments
13.42.11. Major Companies
13.43. Spain Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
13.44. Spain Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.45. Spain Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.46. Spain Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.47. Spain Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.48. Spain Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Eastern Europe Bovine Mastitis Drugs & Diagnostics Market
14.1. Eastern Europe Bovine Mastitis Drugs & Diagnostics Market Overview
14.1.1. Region Information
14.1.2. COVID-19 Impact
14.1.3. Market Information
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulatory Bodies
14.1.7. Regulations
14.1.8. Corporate Tax Structure
14.1.9. Tax Levied
14.1.10. Associations
14.1.11. Investments
14.1.12. Major Companies
14.2. Eastern Europe Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
14.3. Eastern Europe Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
14.4. Eastern Europe Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
14.5. Eastern Europe Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
14.6. Eastern Europe Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
14.7. Eastern Europe Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

15. North America Bovine Mastitis Drugs & Diagnostics Market
15.1. North America Bovine Mastitis Drugs & Diagnostics Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. COVID-19 Impact
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulatory Bodies
15.1.7. Regulations
15.1.8. Corporate Tax Structure
15.1.9. Associations
15.1.10. Tax Levied
15.1.11. Investments
15.1.12. Major Companies
15.2. North America Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
15.3. North America Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
15.4. North America Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.5. North America Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.6. North America Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.7. North America Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.8. North America Bovine Mastitis Drugs & Diagnostics Market: Country Analysis
15.9. USA Bovine Mastitis Drugs & Diagnostics Market
15.10. USA Bovine Mastitis Drugs & Diagnostics Market Overview
15.10.1. Country Information
15.10.2. Market Information
15.10.3. COVID-19 Impact
15.10.4. Background Information
15.10.5. Government Initiatives
15.10.6. Regulatory Bodies
15.10.7. Regulations
15.10.8. Corporate Tax Structure
15.10.9. Associations
15.10.10. Tax Levied
15.10.11. Investments
15.10.12. Major Companies
15.11. USA Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
15.12. USA Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
15.13. USA Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.14. USA Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.15. USA Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.16. USA Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

16. South America Bovine Mastitis Drugs & Diagnostics Market
16.1. South America Bovine Mastitis Drugs & Diagnostics Market Overview
16.1.1. Region Information
16.1.2. COVID-19 Impact
16.1.3. Market Information
16.1.4. Background Information
16.1.5. Regulations
16.1.6. Regulatory Bodies
16.1.7. Corporate Tax Structure
16.1.8. Associations
16.1.9. Investments
16.1.10. Major Companies
16.2. South America Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
16.3. South America Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
16.4. South America Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.5. South America Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.6. South America Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.7. South America Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.8. South America Bovine Mastitis Drugs & Diagnostics Market: Country Analysis
16.9. Brazil Bovine Mastitis Drugs & Diagnostics Market
16.10. Brazil Bovine Mastitis Drugs & Diagnostics Market Overview
16.10.1. Region Information
16.10.2. COVID-19 Impact
16.10.3. Market Information
16.10.4. Background Information
16.10.5. Regulations
16.10.6. Regulatory Bodies
16.10.7. Corporate Tax Structure
16.10.8. Associations
16.10.9. Investments
16.10.10. Major Companies
16.11. Brazil Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
16.12. Brazil Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
16.13. Brazil Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.14. Brazil Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.15. Brazil Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.16. Brazil Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

17. Middle East Bovine Mastitis Drugs & Diagnostics Market
17.1. Middle East Bovine Mastitis Drugs & Diagnostics Market Overview
17.1.1. Region Information
17.1.2. COVID-19 Impact
17.1.3. Market Information
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulatory Bodies
17.1.7. Regulations
17.1.8. Associations
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. Middle East Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.3. Middle East Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.4. Middle East Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.5. Middle East Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.6. Middle East Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.7. Middle East Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Africa Bovine Mastitis Drugs & Diagnostics Market
18.1. Africa Bovine Mastitis Drugs & Diagnostics Market Overview
18.1.1. Region Information
18.1.2. COVID-19 Impact
18.1.3. Market Information
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulatory Bodies
18.1.7. Regulations
18.1.8. Associations
18.1.9. Corporate Tax Structure
18.1.10. Major Companies
18.2. Africa Bovine Mastitis Drugs & Diagnostics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.3. Africa Bovine Mastitis Drugs & Diagnostics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.4. Africa Bovine Mastitis Drugs & Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.5. Africa Bovine Mastitis Diagnostics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.6. Africa Bovine Mastitis Drugs Market, Segmentation by Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.7. Africa Bovine Mastitis Drugs Market, Segmentation by Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Global Bovine Mastitis Drugs & Diagnostics Market Competitive Landscape
19.1. Company Profiles
19.2. Zoetis Inc.
19.2.1. Company Overview
19.2.2. Products and Services
19.2.3. Financial Overview
19.3. Elanco Animal Health
19.3.1. Company Overview
19.3.2. Products and Services
19.3.3. Business Strategy
19.3.4. Financial overview
19.4. Boehringer Ingelheim International GmbH
19.4.1. Company Overview
19.4.2. Products and Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Bayer AG
19.5.1. Company Overview
19.5.2. Products and Services
19.5.3. Business Strategy
19.5.4. Financial Overview
19.6. Merck and Co., Inc.
19.6.1. Company Overview
19.6.2. Products and Services
19.6.3. Business Strategy
19.6.4. Financial Overview

20. Key Mergers and Acquisitions in The Bovine Mastitis Drugs & Diagnostics Market
20.1. Elanco Acquired Bayer’s Animal Health Division
20.2. Thermo Fisher Scientific Acquired QIAGEN
20.3. Advanced Animal Diagnostics Enters Into Agreement With Zoetis
20.4. Locus Biosciences Acquired EpiBiome
20.5. Boehringer Ingelheim Acquired Merial

21. Bovine Mastitis Drugs & Diagnostics Market Opportunities and Strategies
21.1. Global Bovine Mastitis Drugs & Diagnostics Market in 2023 - Countries Offering Most New Opportunities
21.2. Global Bovine Mastitis Drugs & Diagnostics Market in 2023 - Segments Offering Most New Opportunities
21.3. Global Bovine Mastitis Drugs & Diagnostics Market in 2023 - Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies

22. Bovine Mastitis Drugs & Diagnostics Market, Conclusions and Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Price
22.2.3. Promotion
22.2.4. People

23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher
23.6. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Bayer AG
  • Elanco Animal Health
  • Merck and Co., Inc.
  • Zoetis Inc.
  • MORE
This report describes and evaluates the global bovine mastitis drugs & diagnostics market. It covers 2015 to 2019, termed the historic period, 2019 through 2023, the forecast period, 2023-2025 forecast period, and 2025-2030 the forecast period.

The global bovine mastitis drugs & diagnostics market reached a value of nearly $1,508.7 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.5% since 2015. The market is expected to decline from $1,508.7 million in 2019 to $1,322.5 million in 2020 at a rate of -12.3%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 4.6% from 2021 ad reach $1,864.9 million in 2023 at a CAGR of 5.4%. The market is expected to reach $2,046.0 million by 2025 at a CAGR of 4.7%, and $2,705.0 million by 2030 at a CAGR of 5.7%.

Growth in the historic period resulted from prevalence of bovine mastitis, increased spending on cattle, and rise in milk consumption. Factors that negatively affected growth in the historic period were shortages of veterinarians, and lack of awareness. Going forward, economic growth, increasing public spending, and technological advances will drive the growth. Factors that could hinder the growth of the bovine mastitis drugs & diagnostics market in the future include rising threat of antibiotic resistance, reductions in free trade, and development and use of non-antibiotic based treatment.

The bovine mastitis drugs & diagnostics market is segmented by type into bovine mastitis diagnostics, and bovine mastitis drugs. The bovine mastitis drugs market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by type, accounting for 81.5% of the total in 2019. It is also expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by type, going forward, at a CAGR of 5.5% during 2019-2023.

The bovine mastitis drugs & diagnostics market is also segmented by end use into veterinary centers, hospitals & clinics, and other end use. The veterinary centers market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by end use, accounting for 56.8% of the total in 2019. Going forward, the hospitals & clinics segment is expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by end use, going forward, at a CAGR of 5.5% during 2019-2023.

The bovine mastitis diagnostics market is segmented by type into CMT Kits, on-farm diagnostic kits, PCR testing, and others. The CMT kits market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by type, accounting for 44.8% of the total in 2019. Going forward, the on-farm diagnostic kits segment is expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by type, going forward, at a CAGR of 6.2% during 2019-2023.

The bovine mastitis drugs market is segmented by product into antibiotics, pain relievers, vaccines, surgery, and other product. The antibiotics market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by product, accounting for 43.2% of the total in 2019. Going forward, the pain relievers segment is expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by product, going forward, at a CAGR of 6.7% during 2019-2023.

The bovine mastitis drugs market is also segmented by disease into sub-clinical mastitis, and clinical mastitis. The sub-clinical mastitis market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by disease, accounting for 60.3% of the total in 2019. It is also expected to be the fastest growing segment in the bovine mastitis drugs market segmented by disease, going forward, at a CAGR of 5.8% during 2019-2023.

North America was the largest region in the global bovine mastitis drugs & diagnostics market, accounting for 43.8% of the total in 2019. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the bovine mastitis drugs & diagnostics market will be North America, and Asia Pacific, where growth will be at CAGRs of 6.7% and 5.9% respectively. These will be followed by Africa, and the Middle East, where the markets are expected to grow at CAGRs of 5.1% and 3.9% respectively.

The global bovine mastitis drugs & diagnostics market is concentrated, with a small number of large players the market. The top ten competitors in the market made up to 59.4% of the total market in 2019. Major players in the market include Zoetis Inc., Bayer AG, Elanco Animal Health, Merck and Co., Boehringer Ingelheim GmbH.

The top opportunities in the bovine mastitis drugs & diagnostics market segmented by type will arise in the Bovine Mastitis Drugs segment, which will gain $293.5 million of global annual sales by 2023. The top opportunities in the bovine mastitis drugs & diagnostics market segmented by end use will arise in the veterinary centers segment, which will gain $202.2 million of global annual sales by 2023. The top opportunities in the bovine mastitis diagnostics market segmented by product type will arise in the CTM kits segment, which will gain $25.7 million of global annual sales by 2023. The top opportunities in the bovine mastitis drugs market segmented by product will arise in the antibiotics segment, which will gain $110.7 million of global annual sales by 2023. The top opportunities in the bovine mastitis drugs market segmented by disease will arise in the sub-clinical mastitis segment, which will gain $189.3 million of global annual sales by 2023.

Market-trend-based strategies for the bovine mastitis drugs & diagnostics market include investing in the developing nanoparticles as substitutes of conventional drugs, focusing on the research and development of innovative mastitis diagnostic kits, focusing on the development of innovative biosensors to improve bovine mastitis diagnosis, focusing on the development of non-antibiotic therapy, and integrating machine learning. Player-adopted strategies in the bovine mastitis drugs & diagnostics market include expanding through new drugs, expanding through acquisitions, and expanding through strategic collaborations.

The COVID-19 pandemic has decreased short-term potential growth opportunities for the bovine mastitis drugs & diagnostics industry.

To take advantage of the opportunities, the publisher recommends bovine mastitis drugs & diagnostics market companies to invest in nanotechnology, invest in biosensors for bovine mastitis diagnosis, focus on development of non-antibiotic treatment, invest in machine learning, expand in emerging markets, provide competitively priced offerings, participate in veterinary conferences and events and collaborate with veterinarians.
Note: Product cover images may vary from those shown
4 of 5
  • Zoetis Inc.
  • Elanco Animal Health
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Merck and Co., Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll